These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 20581895)

  • 1. Pertussis continues to put New Zealand's immunisation strategy to the test.
    Grant CC; Reid S
    N Z Med J; 2010 Apr; 123(1313):46-61. PubMed ID: 20581895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 1996 pertussis epidemic in New Zealand: descriptive epidemiology.
    Blakely T; Mansoor O; Baker M
    N Z Med J; 1999 Feb; 112(1081):30-3. PubMed ID: 10078212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hospitalisations due to pertussis in New Zealand in the pre-immunisation and mass immunisation eras.
    Somerville RL; Grant CC; Scragg RK; Thomas MG
    J Paediatr Child Health; 2007 Mar; 43(3):147-53. PubMed ID: 17316188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Zealand pertussis epidemiology and the Global Pertussis Initiative immunisation strategies.
    Reid S; Wilson E
    N Z Med J; 2011 Apr; 124(1333):63-4. PubMed ID: 21750599
    [No Abstract]   [Full Text] [Related]  

  • 5. Whooping cough—where are we now? A review.
    Kiedrzynski T; Bissielo A; Suryaprakash M; Bandaranayake D
    N Z Med J; 2015 Jun; 128(1416):21-7. PubMed ID: 26117672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of pertussis in the world.
    Galazka A
    World Health Stat Q; 1992; 45(2-3):238-47. PubMed ID: 1462658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New pertussis vaccination strategies beyond infancy: recommendations by the global pertussis initiative.
    Forsyth KD; Campins-Marti M; Caro J; Cherry JD; Greenberg D; Guiso N; Heininger U; Schellekens J; Tan T; von König CH; Plotkin S;
    Clin Infect Dis; 2004 Dec; 39(12):1802-9. PubMed ID: 15578403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pertussis in infants: preventing deaths and hospitalisations in the very young.
    Wood N; Quinn HE; McIntyre P; Elliott E
    J Paediatr Child Health; 2008 Apr; 44(4):161-5. PubMed ID: 18377367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-specific effectiveness following each dose of acellular pertussis vaccine among infants and children in New Zealand.
    Radke S; Petousis-Harris H; Watson D; Gentles D; Turner N
    Vaccine; 2017 Jan; 35(1):177-183. PubMed ID: 27866766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pertussis--New Zealand 1982/83.
    Begg RC
    N Z Med J; 1984 Jun; 97(758):408-11. PubMed ID: 6589532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential strategies to reduce the burden of pertussis.
    Forsyth K; Tan T; von König CH; Caro JJ; Plotkin S
    Pediatr Infect Dis J; 2005 May; 24(5 Suppl):S69-74. PubMed ID: 15876930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pertussis immunization in the global pertussis initiative international region: recommended strategies and implementation considerations.
    Forsyth K; Nagai M; Lepetic A; Trindade E
    Pediatr Infect Dis J; 2005 May; 24(5 Suppl):S93-7. PubMed ID: 15876935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with immunisation coverage and timeliness in New Zealand.
    Grant CC; Turner NM; York DG; Goodyear-Smith F; Petousis-Harris HA
    Br J Gen Pract; 2010 Mar; 60(572):e113-20. PubMed ID: 20202354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pertussis in early infancy: disease burden and preventive strategies.
    McIntyre P; Wood N
    Curr Opin Infect Dis; 2009 Jun; 22(3):215-23. PubMed ID: 19395958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic analysis of pertussis illness in the Dutch population: implications for current and future vaccination strategies.
    de Greeff SC; Lugnér AK; van den Heuvel DM; Mooi FR; de Melker HE
    Vaccine; 2009 Mar; 27(13):1932-7. PubMed ID: 19368774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using computer simulations to compare pertussis vaccination strategies in Australia.
    Hethcote HW; Horby P; McIntyre P
    Vaccine; 2004 Jun; 22(17-18):2181-91. PubMed ID: 15149775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infants hospitalised with pertussis: estimating the true disease burden.
    Somerville RL; Grant CC; Grimwood K; Murdoch D; Graham D; Jackson P; Meates-Dennis M; Nicholson R; Purvis D
    J Paediatr Child Health; 2007 Sep; 43(9):617-22. PubMed ID: 17608654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
    Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
    Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pertussis in the Netherlands].
    de Greeff SC; de Melker HE; Mooi FR
    Ned Tijdschr Geneeskd; 2010; 154():A1383. PubMed ID: 20170575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of a pertussis booster vaccination program in adolescents and adults on the epidemiology of pertussis in Austria.
    Rendi-Wagner P; Paulke-Korinek M; Stanek G; Khanakah G; Kollaritsch H
    Pediatr Infect Dis J; 2007 Sep; 26(9):806-10. PubMed ID: 17721375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.